IP Library Granted Patent US 8,673,332
Granted Patent B2
US 8,673,332 · App. 13/560,538 · Granted Mar 18, 2014

Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,673,332
App. No.
13/560,538
Granted
Mar 18, 2014
Kind
B2
Abstract

A method and device for local delivery of water-soluble or water-insoluble therapeutic agents to the surface of a normal or diseased body lumen is disclosed. An expandable structure of a medical disposable device, such as a balloon of a balloon catheter, is coated with an amphiphilic polymer coating comprising a therapeutic agent and an amphiphilic polymer or co-polymer. The medical disposable device is inserted into a body lumen, and expanded to contact the amphiphilic polymer coating against the body lumen. The total solubility of the polymer or co-polymer in vivo prevents any embolic hazard associated with the amphiphilic polymer coating.

Claims (11)

1. A medical disposable device comprising: an expandable structure having an outer surface; and an amphiphilic polymer coating disposed on the outer surface of the expandable structure, said amphiphilic polymer coating comprising an amphiphilic polymer or co-polymer complexed with iodine and a hydrophobic therapeutic agent, the amphiphilic polymer or co-polymer selected from the group consisting of hydroxypropyl cellulose, poly (methyl vinyl ether-alt-maleic acid monobutyl ester), and poly (methyl vinyl ether-alt-maleic acid monoethyl ester).

2. The medical disposable device of claim 1 , wherein said therapeutic agent is selected from the group consisting of an anti-proliferative agent, anti-platelet agent, anti-inflammatory agent, anti-thrombotic agent, and thrombolytic agent.

3. The medical disposable device of claim 1 , further comprising a sheath which is extendable over and retractable from said expandable structure.

4. A method of coating a medical disposable device comprising: providing a medical disposable device having an expandable portion and forming an amphiphilic polymer coating on an outer surface of said expandable portion; wherein said amphiphilic polymer coating comprises an amphiphilic polymer or co-polymer complexed with iodine and a hydrophobic therapeutic agent, the amphiphilic polymer or co-polymer selected from the group consisting of hydroxypropyl cellulose, poly (methyl vinyl ether-alt-maleic acid monobutyl ester), and poly (methyl vinyl ether-alt-maleic acid monoethyl ester).

5. The method of claim 4 , wherein said therapeutic agent is selected from the group consisting of an anti-proliferative agent, anti-platelet agent, anti-inflammatory agent, anti-thrombotic agent, and thrombolytic agent.

6. The method of claim 4 , wherein forming said amphiphilic polymer coating comprises dip coating said expandable portion in a coating solution utilizing a single dip.

7. The method of claim 6 , wherein said amphiphilic polymer coating is substantially uniform over the outer surface, and said coating solution has a viscosity of 5 cps to 75 cps.

8. A method of delivering a therapeutic agent to a body lumen comprising: providing a medical disposable device having an amphiphilic polymer coating disposed on an expandable structure of the medical disposable device, wherein said amphiphilic polymer coating comprises an amphiphilic polymer or co-polymer complexed with iodine and a hydrophobic therapeutic agent, the amphiphilic polymer or co-polymer selected from the group consisting of hydroxypropyl cellulose, poly (methyl vinyl ether-alt-maleic acid monobutyl ester), and poly (methyl vinyl ether-alt-maleic acid monoethyl ester); introducing said medical disposable device into a body lumen; and expanding said expandable structure of said medical disposable device to contact said amphiphilic polymer coating against said body lumen.

9. The method of claim 8 , wherein said therapeutic agent is selected from the group consisting of an anti-proliferative agent, anti-platelet agent, anti-inflammatory agent, anti-thrombotic agent, and thrombolytic agent.

10. The method of claim 8 , wherein at least 90% of said amphiphilic polymer coating is dissolved within 300 seconds of said expanding.

11. The method of claim 8 , comprising retracting a sheath from over said expandable structure after introducing said medical disposable device into a body lumen and prior to expanding said expandable structure.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0142 →
RELEASE OF SECURITY INTEREST Recorded Aug 10, 2017
From: MIDCAP FINANCIAL TRUST
To: THE SPECTRANETICS CORPORATION; ANGIOSCORE INC.
Reel/Frame 043518/0066 →
SECURITY INTEREST (REVOLVER) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0425 →
SECURITY INTEREST (TERM) Recorded Dec 11, 2015
From: THE SPECTRANETICS CORPORATION
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 037269/0506 →
RELEASE OF SECURITY INTEREST Recorded Dec 11, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: THE SPECTRANETICS CORPORATION
Reel/Frame 037268/0793 →
SECURITY INTEREST Recorded Jul 2, 2015
From: THE SPECTRANETICS CORPORATION
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 036055/0156 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2015
From: COVIDIEN LP
To: THE SPECTRANETICS CORPORATION
Reel/Frame 035074/0106 →
MERGER Recorded Aug 9, 2013
From: CV INGENUITY LLC
To: COVIDIEN LP
Reel/Frame 030974/0870 →
CHANGE OF NAME Recorded Aug 9, 2013
From: CV INGENUITY CORP.
To: CV INGENUITY LLC
Reel/Frame 030994/0255 →